Ascletis Pharma files HKEX next-day disclosure return on share repurchase for cancellation

PUBT · 2d ago
Ascletis Pharma files HKEX next-day disclosure return on share repurchase for cancellation
  • Ascletis filed a next-day disclosure return showing a 100,000-share buyback for cancellation on July 30.
  • Repurchase price range HKD 8.47 to HKD 8.99; aggregate consideration HKD 867,960.
  • Issued shares excluding treasury shares held steady at 1,051,984,845; treasury shares unchanged at 5,784,210.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260730-12262342), on July 30, 2026, and is solely responsible for the information contained therein.